$336 Million is the total value of Integral Health Asset Management, LLC's 57 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 70.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SAGE | Sell | SAGE THERAPEUTICS INC | $16,869,000 | +20.0% | 195,000 | -15.2% | 5.02% | +16.7% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $15,832,000 | +667.1% | 315,000 | +350.0% | 4.71% | +646.3% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $15,366,000 | +37.0% | 200,000 | +33.3% | 4.57% | +33.2% |
| NVRO | Buy | NEVRO CORP | $15,233,000 | +60.8% | 88,000 | +29.4% | 4.53% | +56.4% |
| LHCG | Sell | LHC GROUP INC | $14,506,000 | -9.0% | 68,000 | -9.3% | 4.32% | -11.5% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $13,243,000 | +77.2% | 53,000 | +60.6% | 3.94% | +72.3% |
| CCXI | Sell | CHEMOCENTRYX INC | $11,146,000 | +9.9% | 180,000 | -2.7% | 3.32% | +6.9% |
| CYTK | Buy | CYTOKINETICS INC | $10,910,000 | +152.0% | 525,000 | +162.5% | 3.24% | +145.1% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $10,794,000 | +74.9% | 320,000 | +28.0% | 3.21% | +70.2% |
| MCK | Sell | MCKESSON CORP | $9,566,000 | +3.6% | 55,000 | -11.3% | 2.84% | +0.7% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $9,533,000 | -2.1% | 85,000 | -19.0% | 2.84% | -4.8% |
| PKI | Sell | PERKINELMER INC | $9,328,000 | -32.4% | 65,000 | -40.9% | 2.77% | -34.3% |
| ANTM | New | ANTHEM INC | $8,991,000 | – | 28,000 | +100.0% | 2.67% | – |
| ABT | Sell | ABBOTT LABS | $8,759,000 | -26.8% | 80,000 | -27.3% | 2.60% | -28.8% |
| LLY | New | LILLY ELI & CO | $8,442,000 | – | 50,000 | +100.0% | 2.51% | – |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $8,367,000 | +32.2% | 72,500 | +11.5% | 2.49% | +28.6% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $8,127,000 | +63.1% | 37,000 | +23.3% | 2.42% | +58.6% |
| BDX | New | BECTON DICKINSON & CO | $8,007,000 | – | 32,000 | +100.0% | 2.38% | – |
| ABBV | New | ABBVIE INC | $7,501,000 | – | 70,000 | +100.0% | 2.23% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $7,454,000 | -18.4% | 85,000 | -29.2% | 2.22% | -20.6% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $6,843,000 | -29.4% | 70,000 | -30.0% | 2.04% | -31.3% |
| CVS | New | CVS HEALTH CORP | $6,830,000 | – | 100,000 | +100.0% | 2.03% | – |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $6,181,000 | +58.6% | 50,000 | +25.0% | 1.84% | +54.2% |
| EHC | New | ENCOMPASS HEALTH CORP | $5,788,000 | – | 70,000 | +100.0% | 1.72% | – |
| AVTR | New | AVANTOR INC | $5,630,000 | – | 200,000 | +100.0% | 1.68% | – |
| JNJ | New | JOHNSON & JOHNSON | $5,508,000 | – | 35,000 | +100.0% | 1.64% | – |
| DNLI | Sell | DENALI THERAPEUTICS INC | $4,816,000 | -18.5% | 57,500 | -65.2% | 1.43% | -20.8% |
| GH | Buy | GUARDANT HEALTH INC | $4,511,000 | +34.5% | 35,000 | +16.7% | 1.34% | +30.8% |
| NTRA | Sell | NATERA INC | $4,478,000 | -6.1% | 45,000 | -31.8% | 1.33% | -8.6% |
| MDT | New | MEDTRONIC PLC | $4,100,000 | – | 35,000 | +100.0% | 1.22% | – |
| ZLAB | Buy | ZAI LAB LTDadr | $4,060,000 | +95.3% | 30,000 | +20.0% | 1.21% | +89.9% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $3,837,000 | – | 50,000 | +100.0% | 1.14% | – |
| SWAV | Buy | SHOCKWAVE MED INC | $3,630,000 | +91.6% | 35,000 | +40.0% | 1.08% | +86.2% |
| PNTG | Sell | PENNANT GROUP INC | $3,484,000 | +20.5% | 60,000 | -20.0% | 1.04% | +17.1% |
| HCA | New | HCA HEALTHCARE INC | $3,289,000 | – | 20,000 | +100.0% | 0.98% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $3,264,000 | – | 60,000 | +100.0% | 0.97% | – |
| GMED | Sell | GLOBUS MED INCcl a | $3,261,000 | +1.3% | 50,000 | -23.1% | 0.97% | -1.5% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $3,250,000 | -22.6% | 75,000 | -37.5% | 0.97% | -24.7% |
| KURA | Buy | KURA ONCOLOGY INC | $3,103,000 | +102.5% | 95,000 | +90.0% | 0.92% | +96.8% |
| AERI | New | AERIE PHARMACEUTICALS INC | $2,702,000 | – | 200,000 | +100.0% | 0.80% | – |
| ALEC | Buy | ALECTOR INC | $2,496,000 | +689.9% | 165,000 | +450.0% | 0.74% | +664.9% |
| BIIB | New | BIOGEN INC | $2,449,000 | – | 10,000 | +100.0% | 0.73% | – |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $2,385,000 | +29.8% | 135,000 | +12.5% | 0.71% | +26.2% |
| AKRO | AKERO THERAPEUTICS INC | $2,193,000 | -16.2% | 85,000 | 0.0% | 0.65% | -18.5% | |
| MGNX | MACROGENICS INC | $2,057,000 | -9.3% | 90,000 | 0.0% | 0.61% | -11.7% | |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $1,950,000 | -46.4% | 15,000 | -40.0% | 0.58% | -47.9% |
| PTCT | PTC THERAPEUTICS INC | $1,837,000 | +30.6% | 30,100 | 0.0% | 0.55% | +27.0% | |
| REPL | New | REPLIMUNE GROUP INC | $1,812,000 | – | 47,500 | +100.0% | 0.54% | – |
| EHTH | Sell | EHEALTH INC | $1,765,000 | -68.1% | 25,000 | -64.3% | 0.52% | -69.0% |
| PGNY | New | PROGYNY INC | $1,696,000 | – | 40,000 | +100.0% | 0.50% | – |
| INSM | Buy | INSMED INC | $1,665,000 | +107.1% | 50,000 | +100.0% | 0.50% | +101.2% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,548,000 | -39.4% | 100,000 | -42.9% | 0.46% | -41.1% |
| MYOV | MYOVANT SCIENCES LTD | $1,381,000 | +96.4% | 50,000 | 0.0% | 0.41% | +91.2% | |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,286,000 | – | 15,000 | +100.0% | 0.38% | – |
| DTIL | Sell | PRECISION BIOSCIENCES INC | $1,168,000 | -36.8% | 140,000 | -53.3% | 0.35% | -38.6% |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $1,026,000 | – | 300,000 | +100.0% | 0.30% | – |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $954,000 | -62.8% | 30,000 | -70.0% | 0.28% | -63.8% |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -50,000 | -100.0% | -0.22% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.26% | – |
| GMAB | Exit | GENMAB A/Ssponsored ads | $0 | – | -30,000 | -100.0% | -0.34% | – |
| Exit | INOVIO PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -0.36% | – | |
| Exit | GOSSAMER BIO INCcall | $0 | – | -100,000 | -100.0% | -0.38% | – | |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -0.44% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -125,000 | -100.0% | -0.54% | – |
| CHWY | Exit | CHEWY INCcl a | $0 | – | -35,000 | -100.0% | -0.59% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -40,000 | -100.0% | -0.61% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -30,000 | -100.0% | -0.71% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -30,000 | -100.0% | -0.73% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -6,000 | -100.0% | -0.76% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -200,000 | -100.0% | -0.76% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -90,000 | -100.0% | -0.83% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -175,000 | -100.0% | -0.83% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -15,000 | -100.0% | -0.84% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -12,000 | -100.0% | -0.87% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -35,000 | -100.0% | -0.92% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -50,000 | -100.0% | -0.92% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -30,000 | -100.0% | -0.98% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -40,000 | -100.0% | -0.98% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -85,000 | -100.0% | -1.04% | – |
| Exit | MODERNA INCput | $0 | – | -50,000 | -100.0% | -1.08% | – | |
| HOLX | Exit | HOLOGIC INC | $0 | – | -55,000 | -100.0% | -1.12% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -155,000 | -100.0% | -1.25% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -14,500 | -100.0% | -1.27% | – |
| Exit | CYTOKINETICS INCcall | $0 | – | -200,000 | -100.0% | -1.32% | – | |
| PODD | Exit | INSULET CORP | $0 | – | -22,000 | -100.0% | -1.59% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -95,000 | -100.0% | -1.70% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -125,000 | -100.0% | -1.92% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -50,000 | -100.0% | -2.08% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -100,000 | -100.0% | -2.54% | – |
| HUM | Exit | HUMANA INC | $0 | – | -26,000 | -100.0% | -3.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.